Glycemic Targets for Pregnant Women With GDM and T2DM
Diabetes Mellitus in Pregnancy, Diabetes, Gestational, Diabetes Mellitus, Type 2
About this trial
This is an interventional treatment trial for Diabetes Mellitus in Pregnancy
Eligibility Criteria
Inclusion Criteria:
- Pregnant women with a singleton gestation
- 18 years or older
- Diagnosis of gestational diabetes (prior to 34 weeks gestational age) or Type 2 diabetes
Exclusion Criteria:
- Diagnosed with gestational diabetes at or beyond 34 weeks gestational age
- Type 1 diabetes
- Diabetic retinopathy
- Diabetic nephropathy
- Diabetic vasculopathy
Sites / Locations
- Los Angeles County + University of Southern California Medical Center (LAC+USC)Recruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control Arm
Interventional Arm
Patients in the control arm will be instructed to check blood sugars seven times per day: fasting, pre-prandial, and 1 hour after each meal. The glycemic targets for the control arm will be defined as follows: fasting ≤95 mg/dL, pre-prandial ≤95 mg/dL, and 1-hour postprandial ≤140 mg/dL (i.e. conventional targets). Patients who do not achieve glycemic goals with diet and exercise will be started on medical therapy (metformin or insulin) at the discretion of a maternal-fetal medicine subspecialist and endocrinologist.
Patients in the experimental arm will be instructed to check blood sugars seven times per day: fasting, pre-prandial, and 1 hour after each meal. The glycemic targets for the intervention arm will be defined as follows: fasting ≤80 mg/dL, pre-prandial ≤80 mg/dL, and 1-hour postprandial ≤110 mg/dL. Patients who do not achieve glycemic goals with diet and exercise will be started on medical therapy (metformin or insulin) at the discretion of a maternal-fetal medicine subspecialist and endocrinologist.